"Well thought through and brilliantly executed" study shows different DNA-repair mechanism in embryos compared to iPSCs
List view / Grid view
Academia and pharma have always been uneasy bedfellows. There has in the past been tension between both caused by a range of issues that neither party was willing to try and resolve. However, there is a new impetus to solve these issues as both parties have started to realise that…
Justin Bryans talks to Drug Target Review about his work as Director of Drug Discovery at the Centre for Therapeutics Discovery, MRC Technology. Justin is also a member of the Drug Target Review Editorial Board.